Vitamin D and probiotic/synbiotic co-supplementation in cardiometabolic disorders: a systematic review and meta-analysis targeting the gut-immune-metabolic axis.
BACKGROUND AND AIM: Vitamin D deficiency and gut microbiota dysregulation are both implicated in the pathophysiology of cardiometabolic disorders. Larger, well-designed randomized controlled trials are needed to confirm these effects and clarify underlying mechanisms.
BACKGROUND AND AIM: Vitamin D deficiency and gut microbiota dysregulation are both implicated in the pathophysiology of cardiometabolic disorders. Larger, well-designed randomized controlled trials are needed to confirm these effects and clarify underlying mechanisms.
What the study was
- Study design
- Randomized Controlled Trial
- Category
- Treatment Innovation
- Maturity
- Potentially Practice-Changing
- Journal
- Nutrition, metabolism, and cardiovascular diseases : NMCD
Why it surfaced
Score 7/10: Randomized Controlled Trial matching topic 'Cardiovascular-metabolic GLP-1 SGLT2'
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.